Mohamad Mohty is Professor of hematology and head of the hematology and cellular
therapy Department at the Saint-Antoine Hospital and Sorbonne University (Paris, France).
Professor Mohty is also head of a translational research team (INSERM team) at the
Saint-Antoine Research center in Paris and his research is focused on the pathophysiology
and immunobiology of normal and pathological antigen-presenting cells, especially the
impact of novel immunomodulatory agents such as proteasome inhibitors, IMiDs and
He has a special clinical focus on the development of reduced-toxicity conditioning
regimens, immunotherapy and different aspects of therapy of acute leukemia and
Professor Mohty is past-president of the European Society for Blood and Marrow
Transplantation (EBMT), and the current chairman of the Acute Leukemia Working
Party of EBMT. He is also co-founder and chairman of the “International Academy for
Clinical Hematology (IACH; http://clinical-hematology.org/).
Professor Mohty has published more than 600 peer-reviewed articles
(https://www.ncbi.nlm.nih.gov/pubmed/?term=MOHTY+M) in the field of stem cell
transplantation, leukemia and myeloma, in different hematology and immunology journals.
He also serves as Editor-in-Chief of the journal Bone Marrow Transplantation, as
Associate Editor for Leukemia, European Journal of Haematology and Blood Cancer
Journal, and as member of the editorial board of Haematologica.